Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

483 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue.
Kwant LE, Vegting Y, Tsang-A-Sjoe MWP, Kwakernaak AJ, Vogt L, Voskuyl AE, van Vollenhoven RF, de Winther MPJ, Bemelman FJ, Anders HJ, Hilhorst ML. Kwant LE, et al. Among authors: van vollenhoven rf. Autoimmun Rev. 2022 Dec;21(12):103211. doi: 10.1016/j.autrev.2022.103211. Epub 2022 Oct 14. Autoimmun Rev. 2022. PMID: 36252930 Free article. Review.
Treat-to-target in systemic lupus erythematosus: where are we today?
Mosca M, Boumpas DT, Bruce IN, Cervera R, Czirjak L, Dörner T, Houssiau F, Jacobsen S, Schneider M, Smolen JS, Voskuyl AE, van Vollenhoven RF. Mosca M, et al. Among authors: van vollenhoven rf. Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S112-5. Epub 2012 Nov 20. Clin Exp Rheumatol. 2012. PMID: 23072706
Remission in SLE: closing in on the target.
van Vollenhoven RF, Voskuyl A, Morand E, Aranow C. van Vollenhoven RF, et al. Ann Rheum Dis. 2015 Dec;74(12):2103-6. doi: 10.1136/annrheumdis-2015-208231. Epub 2015 Oct 28. Ann Rheum Dis. 2015. PMID: 26511997 No abstract available.
Off-label use of rituximab for systemic lupus erythematosus in Europe.
Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R. Rydén-Aulin M, et al. Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163. eCollection 2016. Lupus Sci Med. 2016. PMID: 27651920 Free PMC article.
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT. Fanouriakis A, et al. Among authors: van vollenhoven rf, van leew b. Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27. Ann Rheum Dis. 2020. PMID: 32220834
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.
Boekel L, Steenhuis M, Hooijberg F, Besten YR, van Kempen ZLE, Kummer LY, van Dam KPJ, Stalman EW, Vogelzang EH, Cristianawati O, Keijzer S, Vidarsson G, Voskuyl AE, Wieske L, Eftimov F, van Vollenhoven R, Kuijpers TW, van Ham SM, Tas SW, Killestein J, Boers M, Nurmohamed MT, Rispens T, Wolbink G. Boekel L, et al. Lancet Rheumatol. 2021 Nov;3(11):e778-e788. doi: 10.1016/S2665-9913(21)00222-8. Epub 2021 Aug 6. Lancet Rheumatol. 2021. PMID: 34396154 Free PMC article.
2021 DORIS definition of remission in SLE: final recommendations from an international task force.
van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, Pons-Estel BA, Rahman A, Ugarte-Gil MF, Voskuyl A, Arnaud L, Bruce IN, Cervera R, Costedoat-Chalumeau N, Gordon C, Houssiau FA, Mosca M, Schneider M, Ward MM, Alarcon G, Aringer M, Askenase A, Bae SC, Bootsma H, Boumpas DT, Brunner H, Clarke AE, Coney C, Czirják L, Dörner T, Faria R, Fischer R, Fritsch-Stork R, Inanc M, Jacobsen S, Jayne D, Kuhn A, van Leeuw B, Limper M, Mariette X, Navarra S, Nikpour M, Olesinska MH, Pons-Estel G, Romero-Diaz J, Rubio B, Schoenfeld Y, Bonfá E, Smolen J, Teng YKO, Tincani A, Tsang-A-Sjoe M, Vasconcelos C, Voss A, Werth VP, Zakharhova E, Aranow C. van Vollenhoven RF, et al. Among authors: van leeuw b. Lupus Sci Med. 2021 Nov;8(1):e000538. doi: 10.1136/lupus-2021-000538. Lupus Sci Med. 2021. PMID: 34819388 Free PMC article.
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases.
Boekel L, Hooijberg F, Besten YR, Vogelzang EH, Steenhuis M, Leeuw M, Atiqi S, van Vollenhoven R, Lems WF, Bos WH, Wijbrandts CA, Gerritsen M, Krieckaert C, Voskuyl AE, van der Horst-Bruinsma IE, Tas SW, Boers M, Rispens T, Nurmohamed MT, Wolbink G. Boekel L, et al. Lancet Rheumatol. 2022 May;4(5):e310-e313. doi: 10.1016/S2665-9913(22)00009-1. Epub 2022 Feb 8. Lancet Rheumatol. 2022. PMID: 35156061 Free PMC article. No abstract available.
483 results